FATE Fate Therapeutics, Inc.
Healthcare$2.25+7.14%ClosedMarket Cap: $262.3M
As of 2026-05-25
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
 CNCR | Loncar Cancer Immunotherapy ETF | 17,661 | 3.33% |
 HTEC | ROBO Global Healthcare Technology and Innovation ETF | 29,464 | 0.56% |
 QQQS | Invesco NASDAQ Future Gen 200 ETF | 47,783 | 0.43% |
 WDNA LN | 16,611 | 0.20% | |
 WBIO LN | 17,173 | 0.19% | |
 VMNFX | 308,409 | 0.08% | |
 IJE | 268,985 | 0.03% | |
 IWC | iShares Micro-Cap ETF | 268,985 | 0.03% |
 VSEQX | 2,540,354 | 0.03% | |
 VSTCX | 364,481 | 0.02% | |
 PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 299,527 | 0.01% |
 VTWV | 78,036 | 0.01% | |
 RSSL | Global X - Russell 2000 ETF | 51,509 | 0.01% |
 IWN | iShares Russell 2000 Value ETF | 913,993 | 0.01% |
 NAJ | 913,993 | 0.01% | |
 VTWO | 536,798 | 0.01% | |
 SCHA | Schwab U.S. Small-Cap ETF | 516,435 | 0.00% |
 VHT | 295,141 | 0.00% | |
 VHCIX | 295,141 | 0.00% | |
 VEXAX | 1,069,647 | 0.00% |